NewsRoom Articles - Page 76 of 115 - CanadianCannabisWire

TuesdayApr 02, 2019 11:11 am

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Set to Thrive within Blossoming Cosmeceutical Industry

Therma Bright Inc.’s proprietary technology has received Class II medical device status from the U.S. Food and Drug Administration The global market for cosmeceuticals was valued at nearly $47 billion in 2017 and is estimated to see continued growth The company is waiting on regulatory approvals for its thermal therapy technology, which incorporates the use of cannabis or cannabidiol Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF), a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical (the convergence of cosmetic and pharmaceutical products) industry, offers relief for insect and marine life bites and stings, which is…

MondayApr 01, 2019 1:27 pm

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Readies Online Sales Strategy for New InterceptCS Cold Sore Prevention Device

THRBF offers an IoT- and Bluetooth-enabled device for cold-sore prevention Its sales strategy is part of the company’s larger focus on developing products for the dermatology market THRBF’s proprietary technology is designed to prevent cold sores in the OTC sector, which is projected to record significant sales growth Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) is offering a new generation of technology in the burgeoning skin care market. The company is specifically planning to target sales growth for its high gross-margin InterceptCS* cold sore prevention device with a new website, social media campaign and online sales strategy (http://cnw.fm/7Ahvq). THRBF’s new InterceptCS…

MondayApr 01, 2019 12:58 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Launches Its Largest Cannabinoid Research Program

The R&D program will focus on the proprietary Lexaria DehydraTECH delivery technology with the purpose of enhancing it further Results could contribute to new patent filings in the future; in addition, the program will examine more extensively the way DehydraTECH-enabled CBD outperforms generic CBD Lexaria-designed nanotech enhancements will also be included in the program Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is launching its largest cannabinoid research and development program to date. The program consists of 11 separate animal studies, according to a company press release (http://cnw.fm/YZd5X). The Lexaria in vitro study design was…

FridayMar 29, 2019 12:00 pm

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Expands 7ACRES Cannabis Growing Space

7ACRES cultivation facility’s increase in space set to grow production capacity by 50 percent, reaching approximately 26,250 kg BMO Capital Market analysts initiated coverage of The Supreme Cannabis Company at Market Perform The company is set to launch its line of premium cannabis oil products in April 2019 The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a leading company in the cannabis industry that’s committed to providing premium brands and products, is seeking to grow the world’s best cannabis and become a leader in the global industry. As legalization spreads around the world, the cannabis industry continues…

ThursdayMar 28, 2019 11:56 am

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Receives ‘Speculative Buy’ Rating, Plans Expansion

PLUS received a positive rating, in part, due to its anticipated move into cannabis baked goods and mints PLUS is eyeing expansion into Oregon, Nevada and additional states in the future According to retail sales data, PLUS was California’s number one cannabis-infused edibles brand in retail sales and units sold in Q3 and Q4 2018 Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) has received a ‘Speculative Buy’ rating in its initial coverage by Canaccord Genuity (“CG”), as well as a price target of C$8 (http://cnw.fm/W3ioH). Driving that positive report is the company’s planned move to expand its product line of cannabis…

ThursdayMar 28, 2019 9:00 am

CBD Surges into Mainstream with New Products, Celebrity Endorsements and Emerging Consensus about Benefits

CanadianCannabisWire Editorial Coverage: Analysts at Brightfield Group see CBD (cannabidiol) gobbling up a sizeable chunk of a projected $100 billion nutraceuticals 2022 U.S. market. Growing CBD market could eclipse broader cannabis market Consensus about health benefits backed by clinical work, personal endorsements lead to heightened interest CBD found in vast array of new products As CBD moves into the mainstream, opportunities are likely to grow exponentially for a variety of companies, including plant-based health and wellness product developer Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile). Canadian company Tilray Inc. (NASDAQ: TLRY) is riding the wave by acquiring Manitoba Harvest,…

WednesdayMar 27, 2019 11:08 am

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) Completes Equity-for-Debt Swap

Redfund converts loan into equity position in Mary’s Wellness Ltd. Company’s equity stake totals 5.55 percent of the cannabis-infused tea manufacturer First year global sales for Mary’s Wellness Ltd. forecast to hit $12 million The recent announcement by Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) of an equity-for-debt swap is a good indication of the merchant bank’s innovative approach to providing capital. It also sets up a win-win scenario for both the client, which benefits from reduced leverage and interest payments, and Redfund, which gets a shot at any upside. Arrangements like these demonstrate Redfund’s willingness to work…

WednesdayMar 27, 2019 9:53 am

Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) Employing APP Technology to Transform the Cannabis Beverage Market

Sproutly Canada combining advanced cannabis cultivation and transformational technologies to foster innovation in the cannabis industry The company has acquired biotech company Infusion Biosciences Sproutly owns the exclusive rights to Infusion’s APP technology in various jurisdictions Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) is developing and marketing cannabis consumer products with an emphasis on beverages. The company acquired Infusion Biosciences to bring to market its patent-pending aqueous phytorecovery process (“APP”) technology. This scientific, pioneering discovery of naturally water-soluble cannabinoids is transforming the cannabis beverage market. A Canadian licensed producer, Sproutly Canada has its corporate headquarters in Vancouver, British…

TuesdayMar 26, 2019 1:21 pm

Strategic Acquisition Spree Spurs ‘Buy’ Recommendation for C21 Investments Inc. (CSE: CXXI)

Booming cannabis industry still in early stages and fragmented Industry consolidation inevitable Prospective opportunities likely with consolidators From the shadows, cannabis has surged into the spotlight, establishing medical credence and economic clout along the way. The nascent industry has shaken off early trepidations and has now become a serious and respected sector in the financial arena. Consensus is that both the cannabis markets and the industry itself are just in their early stages and are expected to grow exponentially from here. Much like the early days of the internet gold rush, a multiplicity of business enterprises are sweeping over the…

TuesdayMar 26, 2019 12:25 pm

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Advancing Global Medical Cannabis Strategy

The Supreme Cannabis Company focuses on high-quality cannabis products via its 7ACRES subsidiary The company also has a strategic equity investment in Medigrow Lesotho Supreme has signed a letter of intent with Malta Enterprises BMO recently initiated coverage of Supreme The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) concentrates on growing the world’s best cannabis and becoming a leader in the global industry. The company’s flagship brand is 7ACRES, which is its licensed producer subsidiary that operates a 440,000-square-foot facility in Kincardine, Ontario. The 7ACRES subsidiary received ‘Brand of the Year’ recognition at the 2018 Canadian Cannabis…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 512.354.7000